Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF – Get Free Report) shares crossed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $0.08 and traded as high as $0.0828. Sernova Biotherapeutics shares last traded at $0.0812, with a volume of 11,256 shares changing hands.
Sernova Biotherapeutics Trading Up 5.2%
The company has a market capitalization of $30.66 million, a PE ratio of -2.03 and a beta of 0.90. The business’s fifty day moving average is $0.08 and its two-hundred day moving average is $0.10.
Sernova Biotherapeutics (OTCMKTS:SEOVF – Get Free Report) last released its quarterly earnings data on Thursday, September 10th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01).
Sernova Biotherapeutics Company Profile
Sernova Biotherapeutics is a clinical-stage biotechnology company developing regenerative medicine technologies intended to treat chronic diseases by replacing or supplementing missing or dysfunctional cells. The company’s primary platform is the Cell Pouch System, an implantable device designed to create a vascularized environment that can house therapeutic cells and release biologically active substances into the body. Sernova has focused its research and development activities on cell-based treatments for conditions including insulin-dependent diabetes, hemophilia A and hypothyroidism.
Further Reading
- Five stocks we like better than Sernova Biotherapeutics
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Sernova Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
